ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.080
+0.030 (2.86%)
May 13, 2026, 10:26 AM EDT - Market open
ABVC BioPharma Employees
As of December 31, 2025, ABVC BioPharma had 19 total employees, including 16 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
19
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$416,240
Market Cap
26.69M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2024 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2023 | 19 | -4 | -17.39% | 16 | 3 |
| Dec 31, 2022 | 23 | -7 | -23.33% | 19 | 4 |
| Dec 31, 2021 | 30 | -4 | -11.76% | 28 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 123 |
| Vistagen Therapeutics | 59 |
| Longeveron | 38 |
| Kyntra Bio | 34 |
| Jasper Therapeutics | 22 |
| Lisata Therapeutics | 21 |
| Quantum BioPharma | 17 |
| Barinthus Biotherapeutics | 14 |
ABVC News
- 10 months ago - Sixteen new option listings on July 23rd - TheFly
- 1 year ago - ABVC BioPharma files $100M mixed securities shelf - TheFly
- 1 year ago - ABVC BioPharma believes ABV-1504 can fill void in market after Prozac - TheFly
- 1 year ago - ABVC BioPharma receives $200,000 cash payment from OncoX - TheFly
- 1 year ago - ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners - GlobeNewsWire
- 1 year ago - ABVC BioPharma reports Q3 EPS (2c) vs (82c) last year - TheFly
- 1 year ago - ABVC BioPharma receives $50,000 in incremental licensing fees - TheFly
- 1 year ago - ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners - GlobeNewsWire